Lockheed Q1 FCF Misses as Cash Timing Bites; Guidance Reaffirmed

What happened

Lockheed Martin's Q1 2026 results showed flat sales of $18.0B and EPS of $6.44, but free cash flow turned sharply negative at ($291) million, well below the run-rate implied by the full-year guidance of $6.5B–$6.8B. The weak cash generation reflects higher capex ($2.5B–$2.8B annualized) and working capital headwinds, partially tied to the government shutdown procedures that began early in the year. Management reaffirmed the 2026 outlook, expressing confidence in conversion of missile framework agreements into funded orders later in the year, but the Q1 shortfall introduces execution risk. The historic Orion capsule mission and new multi-year munitions frameworks underscore the demand narrative, yet the underlying cash flow profile remains lumpy and dependent on milestone billings. Investors should note that the company explicitly warned that prolonged shutdown conditions could negatively impact cash flows, and Q1's negative FCF may be an early sign of that drag.

Implication

The reaffirmed 2026 guidance relies on a sharp FCF recovery in later quarters, driven by missile production ramp-ups and framework definitization. If funded awards (PAC-3 MSE, THAAD) materialize, FCF could rebound, but the Q1 miss raises the bar for execution. Until clear evidence of cash conversion appears, the stock's 28.5x P/E offers limited upside.

Thesis delta

The base-case scenario assumed gradual improvement, but Q1's negative FCF introduces downside risk to the $6.6B annual FCF estimate. The thesis now hinges on whether the cash flow shortfall is purely timing—as management suggests—or signals deeper working capital strain. This increases the importance of the next two quarters' cash flow reports and the speed of framework conversion.